Skip to main content
. 2011 Apr 3;4(2):164–168.

Table 2.

The association of insulin sensitivity (glucose disposal rate) and cytokine-mediated inflammation: Multivariable linear regression

hsC-reactive protein lnterleukin-6

β-coefficient (95% CI) p-value β-coefficient (95% CI) p-value
Whole sample (n=1052)
Model A -0.39 (-0.51-(-0.27)) <0.001 -0.28 (-0.40-(-0.15)) <0.001
Model B -0.12 (-0.21-(-0.03)) 0.01 -0.11 (-0.21-(-0.02)) 0.01
Model C -0.13 (-0.23-(-0.03) 0.01 -0.17 (-0.28-(-0.07) <0.001
Without diabetes (n=991)
Model A -0.37 (-0.49-(-0.25)) <0.001 -0.26 (-0.38-(-0.13)) <0.001
Model B -0.13 (-0.22-(-0.04)) 0.006 -0.12 (-0.22-(-0.03)) 0.01
Model C -0.13 (-0.23-(-0.03)) 0.01 -0.17 (-0.28-(-0.07)) <0.001
Without diabetes and without MetS (NCEP) (n = 824)
Model A -0.32 (-0.46-(-0.20)) <0.001 -0.22 (-0.35-(-0.09)) <0.001
Model B -0.12 (-0.22-(-0.01)) 0.03 -0.13 (-0.23-(-0.02)) 0.02
Model C -0.13 (-0.24-(-0.01)) 0.03 -0.17 (-0.29-(-0.06)) 0.004
Normal weight, without diabetes and without MetS
(n=382)
Model A -0.28 (-0.45-(-0.12)) <0.001 -0.26 (-0.44-(-0.07)) 0.007
Model B -0.18 (-0.33-(-0.04)) 0.01 -0.23 (-0.39-(-0.07)) 0.005
Model C -0.20 (-0.36-(-0.03) 0.02 -0.30 (-0.48-(-0.11) 0.002

Data are regression coefficients indicatingthe change in glucose disposal rate (mg/kg bw/min) associated with 1-standard deviation higher hsCRP or IL-6, respectively. Model A adjusted for age, Model B adjusted for the age and the components of the metabolic syndrome (systolic blood pressure, diastolic blood pressure, antihypertensive medication, HDL-cholesterol, triglycerides, lipid lowering treatment, fasting plasma glucose, waist circumference), Model C adjusted for age and lifestyle factors (Body mass index, leisure time physical activity and smoking). Number of participants in the analyses with IL-6: whole sample n=968, without diabetes n = 913, without diabetes and without MetS n = 755, Normal weight, without diabetes and without MetS (n=352): Metabolic syndrome (MetS) was defined usingthe ATP lll-NCEP-definition.